Viewing Study NCT00004067


Ignite Creation Date: 2025-12-25 @ 12:43 AM
Ignite Modification Date: 2025-12-25 @ 10:55 PM
Study NCT ID: NCT00004067
Status: COMPLETED
Last Update Posted: 2021-04-29
First Post: 1999-12-10
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Doxorubicin and Cyclophosphamide Plus Paclitaxel With or Without Trastuzumab in Treating Women With Node-Positive Breast Cancer That Overexpresses HER2
Sponsor: NSABP Foundation Inc
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module